Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

ABUQBEITAH M., DEMIR M., KABASAKAL L., CAVDAR İ., Uslu-Beşli L., YEYIN N., ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.39, sa.11, ss.969-975, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 11
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1097/mnm.0000000000000900
  • Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.969-975
  • Anahtar Kelimeler: dosimetry, empiric dosage, radioiodine, thyroid cancer, BONE-MARROW DOSIMETRY, I-131, BLOOD
  • İstanbul Üniversitesi Adresli: Evet

Özet

Aim The development of reliable dosimetry models promotes the individualized therapy concept toward more success and less complications. This paper evaluates the traditional maximum empirical activity (250 mCi) and the benefit of joining two dosimetry approaches to optimize the therapeutic activity and radioiodine efficacy in metastatic differentiated thyroid cancer.